That is why they need to partner up with a BP that has large R and D capabilities unless LW can wrangle a hell of a buyout price after success in the upcoming CV human trials. IPIX has been lucky to this point having 3 different research labs with large capabilities doing FREE work on the companies behalf. We will see what happens after the likely successful lung tissue trials. There will be a TON of trial and research work needed to be done immediately. Will the government provide everything needed to advance B's progress in future trials. Hopefully so. That would give the company leverage and offset IPIX being forced into another alfasigma deal. Thankfully we will know soon. VERY INTERESTING TIMES COMING IPIX'S WAY...
News 
Market Data 
Discover 
